{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:02:41Z","timestamp":1784512961174,"version":"3.55.0"},"posted":{"date-parts":[[2026,7,20]]},"group-title":"In Review","reference-count":75,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,10]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Onchocerciasis is a disease caused by the filarial nematode parasite\n                  <italic>Onchocerca volvulus<\/italic>\n                  and is transmitted by blackflies after they ingest larval offspring, microfilariae, found in the skin of infected people. The elimination of transmission within endemic communities in sub-Saharan Africa, the Americas, and Yemen depends on mass drug administration of ivermectin (MDAi) at high treatment coverage until the prevalence of the parasite in people or in blackflies reaches below a threshold value. In Africa, there are a number of communities where worms that are less susceptible to the effects of ivermectin, i.e., that are sub-optimally responding (SOR), appear to be contributing to the persistence of onchocerciasis despite high-coverage MDAi. We have incorporated this variation in an epidemiological model to explore how the presence of SOR worms impacts the prevalence of people with skin microfilariae, fitting the model to epidemiological data from a community in Ghana, Asubende, where SOR has been detected. Incorporating a cumulative effect of ivermectin into the model fits the data better than if no cumulative effect is assumed. Simulations indicate that elimination is possible under biannual MDAi even if SOR worms are present in the starting population unless the baseline prevalence is hyperendemic. In a hyperendemic region, elimination is predicted if there is no SOR, but when SOR worms are included in the model, elimination is not reached even after twenty years of biannual MDAi with a treatment coverage of 80%. Biannual MDAi increases the proportion of reproducing female worms that would be characterized as SOR compared to annual MDAi. However, when using mass drug administration with moxidectin (MDAm), elimination becomes possible with fewer rounds of MDA even if there are worms that suboptimally respond to moxidectin. Our results support concerns raised in the research community that SOR to ivermectin in\n                  <italic>O. volvulus<\/italic>\n                  could result in persistent transmission despite high-coverage, biannual MDAi, but that MDAm could pose a solution, should safety and efficacy trials support its distribution.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10311498\/v1","type":"posted-content","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T01:43:46Z","timestamp":1784511826000},"source":"Crossref","is-referenced-by-count":0,"title":["Modelling the impact of mass drug administration with ivermectin or moxidectin on human onchocerciasis when there is sub-optimal response of parasites to treatment"],"prefix":"10.21203","author":[{"given":"Rebecca H","family":"Chisholm","sequence":"first","affiliation":[{"name":"La Trobe University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilian","family":"Xu","sequence":"additional","affiliation":[{"name":"La Trobe University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwadwo K","family":"Frempong","sequence":"additional","affiliation":[{"name":"Noguchi Memorial Institute for Medical Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himal","family":"Shrestha","sequence":"additional","affiliation":[{"name":"The University of Melbourne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Kwadwo Larbi","family":"Opare","sequence":"additional","affiliation":[{"name":"Ghana Health Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odame D","family":"Asiedu","sequence":"additional","affiliation":[{"name":"Ghana Health Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest","family":"Mensah","sequence":"additional","affiliation":[{"name":"Ghana Health Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makedonka","family":"Mitreva","sequence":"additional","affiliation":[{"name":"Washington University in St. Louis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warwick N","family":"Grant","sequence":"additional","affiliation":[{"name":"La Trobe University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon M","family":"Hedtke","sequence":"additional","affiliation":[{"name":"La Trobe University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetpar.2015.04.002","article-title":"Macrocyclic lactone resistance in Dirofilaria immitis: Failure of heartworm preventives and investigation of genetic markers for resistance","volume":"210","author":"Bourguinat C","year":"2015","unstructured":"Bourguinat C, Lee AC, Lizundia R, Blagburn BL, Liotta JL, Kraus MS, et al. Macrocyclic lactone resistance in Dirofilaria immitis: Failure of heartworm preventives and investigation of genetic markers for resistance. Vet Parasitol. 2015;210 3\u20134:167\u2009\u2013\u200978; doi: 10.1016\/j.vetpar.2015.04.002. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25936435.","journal-title":"Vet Parasitol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e0005816","DOI":"10.1371\/journal.pntd.0005816","article-title":"Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity","volume":"11 7","author":"Doyle SR","year":"2017","unstructured":"Doyle SR, Bourguinat C, Nana-Djeunga HC, Kengne-Ouafo JA, Pion SDS, Bopda J, et al. Genome-wide analysis of ivermectin response by Onchocerca volvulus reveals that genetic drift and soft selective sweeps contribute to loss of drug sensitivity. PLoS Negl Trop Dis. 2017;11 7:e0005816; doi: 10.1371\/journal.pntd.0005816. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28746337.","journal-title":"PLoS Negl Trop Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpddr.2021.12.002","article-title":"Genome-wide analysis of the response to ivermectin treatment by a Swedish field population of Haemonchus contortus","volume":"18","author":"Baltrusis P","year":"2022","unstructured":"Baltrusis P, Doyle SR, Halvarsson P, Hoglund J. Genome-wide analysis of the response to ivermectin treatment by a Swedish field population of Haemonchus contortus. Int J Parasitol Drugs Drug Resist. 2022;18:12\u20139; doi: 10.1016\/j.ijpddr.2021.12.002. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34959200.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e1006857","DOI":"10.1371\/journal.pgen.1006857","article-title":"Genomic introgression mapping of field-derived multiple-anthelmintic resistance in Teladorsagia circumcincta","volume":"13 6","author":"Choi YJ","year":"2017","unstructured":"Choi YJ, Bisset SA, Doyle SR, Hallsworth-Pepin K, Martin J, Grant WN, et al. Genomic introgression mapping of field-derived multiple-anthelmintic resistance in Teladorsagia circumcincta. PLoS Genet. 2017;13 6:e1006857; doi: 10.1371\/journal.pgen.1006857. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28644839.","journal-title":"PLoS Genet."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0020-7519(94)90008-6","article-title":"Genetic variation in parasitic nematodes and its implications","volume":"24 6","author":"Grant WN","year":"1994","unstructured":"Grant WN. Genetic variation in parasitic nematodes and its implications. Int J Parasitol. 1994;24 6:821\u201330. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7982744.","journal-title":"Int J Parasitol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3389\/fgene.2019.01282","article-title":"Genomic epidemiology in filarial nematodes: transforming the basis for elimination program decisions","volume":"10","author":"Hedtke SM","year":"2020","unstructured":"Hedtke SM, Kuesel AC, Crawford KE, Graves PM, Boussinesq M, Lau CL, et al. Genomic epidemiology in filarial nematodes: transforming the basis for elimination program decisions. Front Genet. 2020;10:1282; doi: 10.3389\/fgene.2019.01282. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31998356.","journal-title":"Front Genet"},{"issue":"1:1099","key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45027-2","article-title":"Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy","volume":"15","author":"Coffeng LE","year":"2024","unstructured":"Coffeng LE, Stolk WA, de Vlas SJ. Predicting the risk and speed of drug resistance emerging in soil-transmitted helminths during preventive chemotherapy. Nat Commun. 2024;15 1:1099; doi: 10.1038\/s41467-024-45027-2. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/38321011.","journal-title":"Nat Commun."},{"key":"ref8","first-page":"572","article-title":"Elimination of human onchocerciasis: progress report, 2022\u20132023 \u2013 \u00c9limination de l\u2019onchocercose humaine: rapport de situation, 2022\u20132023","volume":"98 45","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. Elimination of human onchocerciasis: progress report, 2022\u20132023 \u2013 \u00c9limination de l\u2019onchocercose humaine: rapport de situation, 2022\u20132023. Weekly Epidemiological Record. 2023;98 45:572\u201382. https:\/\/iris.who.int\/handle\/10665\/373991.","journal-title":"Weekly Epidemiological Record"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.micinf.2003.11.003","article-title":"Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria","volume":"6","author":"Brattig NW","year":"2004","unstructured":"Brattig NW. Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria. Microbes and Infection. 2004;6 1:113\u2009\u2013\u200928; doi: https:\/\/doi.org\/10.1016\/j.micinf.2003.11.003. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1286457903003101.","journal-title":"Microbes and Infection"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/S1473-3099(18)30425-0","article-title":"The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study","volume":"18 11","author":"Chesnais CB","year":"2018","unstructured":"Chesnais CB, Nana-Djeunga HC, Njamnshi AK, Lenou-Nanga CG, Boulle C, Bissek AZ, et al. The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study. Lancet Infect Dis. 2018;18 11:1278\u201386; doi: 10.1016\/S1473-3099(18)30425-0. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30268645.","journal-title":"Lancet Infect Dis"},{"key":"ref11","first-page":"431","article-title":"Worm burden of Onchocerca volvulus in a hyperendemic village of the rain-forest in West Africa","volume":"28 4","author":"Schulz-Key H","year":"1977","unstructured":"Schulz-Key H, Albiez EJ. Worm burden of Onchocerca volvulus in a hyperendemic village of the rain-forest in West Africa. Tropenmedizin und Parasitologie. 1977;28 4:431\u20138.","journal-title":"Tropenmedizin und Parasitologie"},{"key":"ref12","first-page":"387","article-title":"On the reproductive activity of the female Onchocerca volvulus","volume":"41 4","author":"Duke BO","year":"1990","unstructured":"Duke BO, Zea-Flores G, Gannon RT. On the reproductive activity of the female Onchocerca volvulus. Trop Med Parasitol. 1990;41 4:387\u2013402. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2075383.","journal-title":"Trop Med Parasitol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e0013221","DOI":"10.1371\/journal.pntd.0013221","article-title":"Genetic structuring and estimation of reproductive adults in Onchocerca volvulus: A genome-wide analysis across hosts and regions","volume":"19 7","author":"Kumar P","year":"2025","unstructured":"Kumar P, Choi YJ, Fischer K, Hedtke SM, Kode A, Opoku N, et al. Genetic structuring and estimation of reproductive adults in Onchocerca volvulus: A genome-wide analysis across hosts and regions. PLoS Negl Trop Dis. 2025;19 7:e0013221; doi: 10.1371\/journal.pntd.0013221. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/40591654.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref14","first-page":"61","article-title":"The population dynamics of Onchocerca volvulus in the human host","volume":"44","author":"Duke BO","year":"1993","unstructured":"Duke BO. The population dynamics of Onchocerca volvulus in the human host. Trop Med Parasitol. 1993;44 2:61\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8367667.","journal-title":"Trop Med Parasitol"},{"key":"ref15","first-page":"163","article-title":"Studies on nodules and adult Onchocerca volvulus during a nodulectomy trial in hyperendemic villages in Liberia and Upper Volta. II. Comparison of the macrofilaria population in adult nodule carriers","volume":"35","author":"Albiez EJ","year":"1984","unstructured":"Albiez EJ, B\u00fcttner DW, Schulz-Key H. Studies on nodules and adult Onchocerca volvulus during a nodulectomy trial in hyperendemic villages in Liberia and Upper Volta. II. Comparison of the macrofilaria population in adult nodule carriers. Tropenmed Parasitol. 1984;35:163\u20136.","journal-title":"Tropenmed Parasitol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3390\/pathogens12070971","article-title":"Assessing intensity of infection and genetic diversity of onchocerciasis using mitochondrial genome sequencing of single microfilariae","volume":"12 7","author":"Hedtke SM","year":"2023","unstructured":"Hedtke SM, Choi Y-J, Kode A, Chalasani GC, Sirwani N, Jada SR, et al. Assessing intensity of infection and genetic diversity of onchocerciasis using mitochondrial genome sequencing of single microfilariae. Pathogens. 2023;12 7:971; doi: 10.3390\/pathogens12070971.","journal-title":"Pathogens"},{"key":"ref17","volume-title":"African Programme for Onchocerciasis Control: Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment","author":"World Health Organization","year":"2010","unstructured":"World Health Organization, African Programme for Onchocerciasis Control: Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment. vol. WHO\/APOC\/MG\/10.1. Burkina Faso: World Health Organization; 2010."},{"key":"ref18","volume-title":"Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures","author":"World Health Organization","year":"2016","unstructured":"World Health Organization: Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures. Geneva: World Health Organization; 2016."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(84)90671-8","article-title":"Ivermectin in onchocerciasis","volume":"2 8408","author":"Awadzi K","year":"1984","unstructured":"Awadzi K, Dadzie KY, Schulz-Key H, Haddock DR, Gilles HM, Aziz MA. Ivermectin in onchocerciasis. Lancet. 1984;2 8408:921. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6148634.","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13071-015-0779-4","article-title":"The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data","volume":"8","author":"Turner HC","year":"2015","unstructured":"Turner HC, Walker M, Attah SK, Opoku NO, Awadzi K, Kuesel AC, et al. The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data. Parasit Vectors. 2015;8:167; doi: 10.1186\/s13071-015-0779-4. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25889256.","journal-title":"Parasit Vectors."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/S0140-6736(17)32844-1","article-title":"Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial","volume":"392 10154","author":"Opoku NO","year":"2018","unstructured":"Opoku NO, Bakajika DK, Kanza EM, Howard H, Mambandu GL, Nyathirombo A, et al. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial. Lancet. 2018;392 10154:1207\u201316; doi: 10.1016\/S0140-6736(17)32844-1. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29361335.","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0010079","DOI":"10.1371\/journal.pntd.0010079","article-title":"Effect of a single dose of 8 mg moxidectin or 150 \u00b5g\/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection","volume":"16 4","author":"Bakajika D","year":"2022","unstructured":"Bakajika D, Kanza EM, Opoku NO, Howard HM, Mambandu GL, Nyathirombo A, et al. Effect of a single dose of 8 mg moxidectin or 150 \u00b5g\/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection. PLoS Negl Trop Dis. 2022;16 4:e0010079; doi: 10.1371\/journal.pntd.0010079. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/35476631.","journal-title":"PLoS Negl Trop Dis."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e2953","DOI":"10.1371\/journal.pntd.0002953","article-title":"A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection","volume":"8 6","author":"Awadzi K","year":"2014","unstructured":"Awadzi K, Opoku NO, Attah SK, Lazdins-Helds J, Kuesel AC. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection. PLoS Negl Trop Dis. 2014;8 6:e2953; doi: 10.1371\/journal.pntd.0002953. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24968000.","journal-title":"PLoS Negl Trop Dis."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13071-018-2864-y","article-title":"Modelling the impact of larviciding on the population dynamics and biting rates of Simulium damnosum (s.l.): implications for vector control as a complementary strategy for onchocerciasis elimination in Africa","volume":"11 1","author":"Routledge I","year":"2018","unstructured":"Routledge I, Walker M, Cheke RA, Bhatt S, Nkot PB, Matthews GA, et al. Modelling the impact of larviciding on the population dynamics and biting rates of Simulium damnosum (s.l.): implications for vector control as a complementary strategy for onchocerciasis elimination in Africa. Parasites & Vectors. 2018;11 1:316; doi: 10.1186\/s13071-018-2864-y. https:\/\/doi.org\/10.1186\/s13071-018-2864-y.","journal-title":"Parasites & Vectors."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e0010005","DOI":"10.1371\/journal.pntd.0010005","article-title":"Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection","volume":"16 3","author":"Tan B","year":"2022","unstructured":"Tan B, Opoku N, Attah SK, Awadzi K, Kuesel AC, Lazdins-Helds J, et al. Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection. PLOS Neglected Tropical Diseases. 2022;16 3:e0010005; doi: 10.1371\/journal.pntd.0010005. https:\/\/doi.org\/10.1371\/journal.pntd.0010005.","journal-title":"PLOS Neglected Tropical Diseases."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13071-025-06891-z","article-title":"Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety study","volume":"18 1","author":"Opoku NO","year":"2025","unstructured":"Opoku NO, Doe F, Agbogah ME, Laryea R, Gordor SK, Donkor BS, et al. Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety study. Parasit Vectors. 2025;18 1:295; doi: 10.1186\/s13071-025-06891-z. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/40707999.","journal-title":"Parasit Vectors."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0169-2607(90)90030-D","article-title":"ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis","volume":"31 1","author":"Plaisier AP","year":"1990","unstructured":"Plaisier AP, van Oortmarssen GJ, Habbema JD, Remme J, Alley ES. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Comput Methods Programs Biomed. 1990;31 1:43\u201356. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2311368.","journal-title":"Comput Methods Programs Biomed"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007557","author":"Hamley JID","year":"2019","unstructured":"Hamley JID, Milton P, Walker M, Bas\u00e1\u00f1ez MG. Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs. PLoS Negl Trop Dis. 2019;13 12:e0007557; doi: 10.1371\/journal.pntd.0007557. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31805049."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1098\/rstb.1999.0433","article-title":"Population biology of human onchocerciasis. Philos Trans R Soc Lond B Biol Sci","volume":"354 1384","author":"Bas\u00e1\u00f1ez MG","year":"1999","unstructured":"Bas\u00e1\u00f1ez MG, Boussinesq M. Population biology of human onchocerciasis. Philos Trans R Soc Lond B Biol Sci. 1999;354 1384:809\u201326; doi: 10.1098\/rstb.1999.0433. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10365406."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e115886","DOI":"10.1371\/journal.pone.0115886","article-title":"Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment","volume":"9 12","author":"Coffeng LE","year":"2014","unstructured":"Coffeng LE, Stolk WA, Hoerauf A, Habbema D, Bakker R, Hopkins AD, et al. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment. PLoS One. 2014;9 12:e115886; doi: 10.1371\/journal.pone.0115886. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25545677.","journal-title":"PLoS One."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1186\/s13071-015-1159-9","article-title":"Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis","volume":"8","author":"Stolk WA","year":"2015","unstructured":"Stolk WA, Walker M, Coffeng LE, Bas\u00e1\u00f1ez MG, de Vlas SJ. Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis. Parasit Vectors. 2015;8:552; doi: 10.1186\/s13071-015-1159-9. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26489937.","journal-title":"Parasit Vectors."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1471-4922(01)02013-X","article-title":"Models for the population biology and control of human onchocerciasis","volume":"17 9","author":"Bas\u00e1\u00f1ez MG","year":"2001","unstructured":"Bas\u00e1\u00f1ez MG, Ricardez-Esquinca J. Models for the population biology and control of human onchocerciasis. Trends Parasitol. 2001;17 9:430\u20138. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11530355.","journal-title":"Trends Parasitol."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/bs.apar.2016.08.003","article-title":"River blindness: mathematical models for control and elimination","volume":"94","author":"Bas\u00e1\u00f1ez MG","year":"2016","unstructured":"Bas\u00e1\u00f1ez MG, Walker M, Turner HC, Coffeng LE, de Vlas SJ, Stolk WA. River blindness: mathematical models for control and elimination. Adv Parasitol. 2016;94:247\u2013341; doi: 10.1016\/bs.apar.2016.08.003. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27756456.","journal-title":"Adv Parasitol."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1137","author":"Verver S","year":"2018","unstructured":"Verver S, Walker M, Kim YE, Fobi G, Tekle AH, Zoure HGM, et al. How can onchocerciasis elimination in Africa be accelerated? Modeling the impact of increased ivermectin treatment frequency and complementary vector control. Clin Infect Dis. 2018;66 suppl_4:S267-S74; doi: 10.1093\/cid\/cix1137. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29860291."},{"issue":"Suppl 3","key":"ref35","doi-asserted-by":"publisher","first-page":"S165-S71","DOI":"10.1093\/cid\/ciab238","article-title":"Scaling-down mass ivermectin treatment for onchocerciasis elimination: modeling the impact of the geographical unit for decision making","volume":"72","author":"Stolk WA","year":"2021","unstructured":"Stolk WA, Blok DJ, Hamley JID, Cantey PT, de Vlas SJ, Walker M, et al. Scaling-down mass ivermectin treatment for onchocerciasis elimination: modeling the impact of the geographical unit for decision making. Clin Infect Dis. 2021;72 Suppl 3:S165-S71; doi: 10.1093\/cid\/ciab238. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33909070.","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e0009011","DOI":"10.1371\/journal.pntd.0009011","article-title":"The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages","volume":"15 5","author":"Vos AS","year":"2021","unstructured":"de Vos AS, Stolk WA, Coffeng LE, de Vlas SJ. The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages. PLoS Negl Trop Dis. 2021;15 5:e0009011; doi: 10.1371\/journal.pntd.0009011. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33979331.","journal-title":"PLoS Negl Trop Dis."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"15265","DOI":"10.1073\/pnas.0502659102","article-title":"Human infection patterns and heterogeneous exposure in river blindness","volume":"102 42","author":"Filipe JA","year":"2005","unstructured":"Filipe JA, Boussinesq M, Renz A, Collins RC, Vivas-Martinez S, Grillet ME, et al. Human infection patterns and heterogeneous exposure in river blindness. Proc Natl Acad Sci U S A. 2005;102 42:15265\u201370; doi: 10.1073\/pnas.0502659102. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16217028.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"e0006624","DOI":"10.1371\/journal.pntd.0006624","article-title":"The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis","volume":"12 10","author":"Vos AS","year":"2018","unstructured":"de Vos AS, Stolk WA, de Vlas SJ, Coffeng LE. The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis. PLoS Negl Trop Dis. 2018;12 10:e0006624; doi: 10.1371\/journal.pntd.0006624. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30296264.","journal-title":"PLoS Negl Trop Dis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e2169","DOI":"10.1371\/journal.pntd.0002169","article-title":"Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis","volume":"7 4","author":"Turner HC","year":"2013","unstructured":"Turner HC, Churcher TS, Walker M, Osei-Atweneboana MY, Prichard RK, Bas\u00e1\u00f1ez MG. Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis. PLoS Negl Trop Dis. 2013;7 4:e2169; doi: 10.1371\/journal.pntd.0002169. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23634234.","journal-title":"PLoS Negl Trop Dis."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e0009489","DOI":"10.1371\/journal.pntd.0009489","article-title":"How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?","volume":"15 6","author":"Vinkeles Melchers NVS","year":"2021","unstructured":"Vinkeles Melchers NVS, Stolk WA, Murdoch ME, Pedrique B, Kloek M, Bakker R, et al. How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment? PLoS Negl Trop Dis. 2021;15 6:e0009489; doi: 10.1371\/journal.pntd.0009489. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34115752.","journal-title":"PLoS Negl Trop Dis"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"20220277","DOI":"10.1098\/rstb.2022.0277","article-title":"Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa? Philos Trans R Soc Lond B Biol Sci","volume":"378 1887","author":"Kura K","year":"2023","unstructured":"Kura K, Milton P, Hamley JID, Walker M, Bakajika DK, Kanza EM, et al. Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa? Philos Trans R Soc Lond B Biol Sci. 2023;378 1887:20220277; doi: 10.1098\/rstb.2022.0277. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37598705."},{"key":"ref42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1179\/000349804225003442","article-title":"Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana","volume":"98 4","author":"Awadzi K","year":"2004","unstructured":"Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, Lazdins-Helds JK, et al. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol. 2004;98 4:359\u201370; doi: 10.1179\/000349804225003442. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15228717.","journal-title":"Ann Trop Med Parasitol."},{"key":"ref43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1179\/000349804225003253","article-title":"An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana","volume":"98 3","author":"Awadzi K","year":"2004","unstructured":"Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, Osei-Atweneboana MY, et al. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol. 2004;98 3:231\u201349; doi: 10.1179\/000349804225003253. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15119969.","journal-title":"Ann Trop Med Parasitol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/S0140-6736(07)60942-8","article-title":"Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study","volume":"369 9578","author":"Osei-Atweneboana MY","year":"2007","unstructured":"Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet. 2007;369 9578:2021\u20139; doi: 10.1016\/S0140-6736(07)60942-8. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17574093.","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"16716","DOI":"10.1073\/pnas.0906176106","article-title":"Identifying sub-optimal responses to ivermectin in the treatment of River Blindness","volume":"106 39","author":"Churcher TS","year":"2009","unstructured":"Churcher TS, Pion SD, Osei-Atweneboana MY, Prichard RK, Awadzi K, Boussinesq M, et al. Identifying sub-optimal responses to ivermectin in the treatment of River Blindness. Proc Natl Acad Sci U S A. 2009;106 39:16716\u201321; doi: 10.1073\/pnas.0906176106. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19805362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1371\/journal.pntd.0000998","article-title":"Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus","volume":"5 3","author":"Osei-Atweneboana MY","year":"2011","unstructured":"Osei-Atweneboana MY, Awadzi K, Attah SK, Boakye DA, Gyapong JO, Prichard RK. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl Trop Dis. 2011;5 3:e998; doi: 10.1371\/journal.pntd.0000998. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21468315.","journal-title":"PLoS Negl Trop Dis."},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002084","author":"Pion SD","year":"2013","unstructured":"Pion SD, Nana-Djeunga HC, Kamgno J, Tendongfor N, Wanji S, Njiokou F, et al. Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naive and a multiply treated population from Cameroon. PLoS Negl Trop Dis. 2013;7 2:e2084; doi: 10.1371\/journal.pntd.0002084. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23469307."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e2824","DOI":"10.1371\/journal.pntd.0002824","article-title":"Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naive and a frequently treated population from Cameroon","volume":"8 4","author":"Nana-Djeunga HC","year":"2014","unstructured":"Nana-Djeunga HC, Bourguinat C, Pion SD, Bopda J, Kengne-Ouafo JA, Njiokou F, et al. Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naive and a frequently treated population from Cameroon. PLoS Negl Trop Dis. 2014;8 4:e2824; doi: 10.1371\/journal.pntd.0002824. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24762816.","journal-title":"PLoS Negl Trop Dis."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/cid\/ciw144","article-title":"Does increasing treatment frequency address suboptimal responses to ivermectin for the control and elimination of River blindness?","volume":"62 11","author":"Frempong KK","year":"2016","unstructured":"Frempong KK, Walker M, Cheke RA, Tetevi EJ, Gyan ET, Owusu EO, et al. Does increasing treatment frequency address suboptimal responses to ivermectin for the control and elimination of River blindness? Clin Infect Dis. 2016;62 11:1338\u201347; doi: 10.1093\/cid\/ciw144. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27001801.","journal-title":"Clin Infect Dis."},{"issue":"1:726","key":"ref50","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05444-2","article-title":"Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment","volume":"20","author":"Abong RA","year":"2020","unstructured":"Abong RA, Amambo GN, Chounna Ndongmo PW, Njouendou AJ, Ritter M, Beng AA, et al. Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment. BMC Infect Dis. 2020;20 1:726; doi: 10.1186\/s12879-020-05444-2. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33008333.","journal-title":"BMC Infect Dis."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/1756-3305-7-241","article-title":"Modelling the impact of ivermectin on River blindness and its burden of morbidity and mortality in African savannah: EpiOncho projections","volume":"7","author":"Turner HC","year":"2014","unstructured":"Turner HC, Walker M, Churcher TS, Bas\u00e1\u00f1ez MG. Modelling the impact of ivermectin on River blindness and its burden of morbidity and mortality in African savannah: EpiOncho projections. Parasit Vectors. 2014;7:241; doi: 10.1186\/1756-3305-7-241. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24886747.","journal-title":"Parasit Vectors."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e2452","DOI":"10.1371\/journal.pntd.0002452","article-title":"The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study","volume":"7 9","author":"Turner HC","year":"2013","unstructured":"Turner HC, Osei-Atweneboana MY, Walker M, Tettevi EJ, Churcher TS, Asiedu O, et al. The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study. PLoS Negl Trop Dis. 2013;7 9:e2452; doi: 10.1371\/journal.pntd.0002452. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24069497.","journal-title":"PLoS Negl Trop Dis"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/cid\/ciu467","article-title":"Reaching the London Declaration on Neglected Tropical Diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa","volume":"59 7","author":"Turner HC","year":"2014","unstructured":"Turner HC, Walker M, Churcher TS, Osei-Atweneboana MY, Biritwum NK, Hopkins A, et al. Reaching the London Declaration on Neglected Tropical Diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa. Clin Infect Dis. 2014;59 7:923\u201332; doi: 10.1093\/cid\/ciu467. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24944228.","journal-title":"Clin Infect Dis."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1:204","DOI":"10.1093\/infdis\/172.1.204","article-title":"Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa","volume":"172","author":"Plaisier AP","year":"1995","unstructured":"Plaisier AP, Alley ES, Boatin BA, Van Oortmarssen GJ, Remme H, De Vlas SJ, et al. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa. J Infect Dis. 1995;172 1:204\u201310. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7797912.","journal-title":"J Infect Dis."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70099-9","article-title":"Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis","volume":"8","author":"Bas\u00e1\u00f1ez M-G","year":"2008","unstructured":"Bas\u00e1\u00f1ez M-G, Pion SD, Boakes E, Filipe JA, Churcher TS, Boussinesq M. Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8 5:310\u2009\u2013\u200922; doi: 10.1016\/S1473-3099(08)70099-9. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18471776.","journal-title":"Lancet Infect Dis."},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1017\/S0031182008000425","article-title":"Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments","volume":"135 13","author":"Bottomley C","year":"2008","unstructured":"Bottomley C, Isham V, Collins RC, Bas\u00e1\u00f1ez MG. Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments. Parasitology. 2008;135 13:1571\u201381; doi: 10.1017\/S0031182008000425. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18831801.","journal-title":"Parasitology."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"21934","DOI":"10.48550\/arXiv.2505.21934","article-title":"Beyond data: leveraging non-empirical information and expert knowledge in Bayesian model calibration","volume":"2505","author":"Vollert SA","unstructured":"Vollert SA, Drovandi C, Jeyes-Smith C, Pascal LV, Adams MP. Beyond data: leveraging non-empirical information and expert knowledge in Bayesian model calibration. arXiv. 2025:arXiv:2505:21934; doi: 10.48550\/arXiv.2505.21934.","journal-title":"arXiv. 2025:arXiv"},{"key":"ref58","author":"Soetaert K","year":"2010","unstructured":"Soetaert K, Petzoldt T, Setzer RW. Solving Differential Equations in R. R J. 2010;2 2:5\u201315. <Go to ISI>:\/\/WOS:000208590000002."},{"key":"ref59","article-title":"The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug effects","volume":"39","author":"Schulz-Key H","year":"1988","unstructured":"Schulz-Key H. The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug effects. Trop Med Parasitol. 1988;39 Suppl 4:423\u2009\u2013\u200940. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2852394.","journal-title":"Trop Med Parasitol"},{"issue":"1\u20132","key":"ref60","first-page":"27","article-title":"Observations on the reproductive biology of Onchocerca volvulus","volume":"59","author":"Schulz-Key H","year":"1990","unstructured":"Schulz-Key H. Observations on the reproductive biology of Onchocerca volvulus. Acta Leiden. 1990;59 1\u20132:27\u201344. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2378210.","journal-title":"Acta Leiden"},{"key":"ref61","first-page":"4:428","article-title":"Isolation of living adult Onchocerca volvulus from nodules","volume":"28","author":"Schulz-Key H","year":"1977","unstructured":"Schulz-Key H, Albiez EJ, Buttner DW. Isolation of living adult Onchocerca volvulus from nodules. Tropenmed Parasitol. 1977;28 4:428\u201330.","journal-title":"Tropenmed Parasitol."},{"key":"ref62","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0169-4758(86)90138-9","article-title":"Periodic reproduction of Onchocerca volvulus","volume":"2 10","author":"Schulz-Key H","year":"1986","unstructured":"Schulz-Key H, Karam M. Periodic reproduction of Onchocerca volvulus. Parasitol Today. 1986;2 10:284\u20136. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15462735.","journal-title":"Parasitol Today"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09456-4","article-title":"Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial","volume":"360","author":"Gardon J","year":"2002","unstructured":"Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga N, Duke BO. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet. 2002;360 9328:203\u2009\u2013\u200910; doi: 10.1016\/S0140-6736(02)09456-4. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12133654.","journal-title":"Lancet"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4269\/ajtmh.2005.73.1159","article-title":"Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year","volume":"73 6","author":"Cupp EW","year":"2005","unstructured":"Cupp EW, Cupp MS. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year. Am J Trop Med Hyg. 2005;73 6:1159\u201361. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16354830.","journal-title":"Am J Trop Med Hyg"},{"key":"ref65","author":"!!!","unstructured":"!!! INVALID CITATION !!! [2]."},{"key":"ref66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-4017(99)00131-4","article-title":"Decreased ivermectin and moxidectin sensitivity in Haemonchus contortus selected with moxidectin over 14 generations","volume":"86 1","author":"Molento MB","year":"1999","unstructured":"Molento MB, Wang GT, Prichard RK. Decreased ivermectin and moxidectin sensitivity in Haemonchus contortus selected with moxidectin over 14 generations. Vet Parasitol. 1999;86 1:77\u201381. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10489206.","journal-title":"Vet Parasitol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0166-6851(98)00087-5","article-title":"Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus","volume":"95 2","author":"Blackhall WJ","year":"1998","unstructured":"Blackhall WJ, Liu HY, Xu M, Prichard RK, Beech RN. Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus. Mol Biochem Parasitol. 1998;95 2:193\u2013201. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9803412.","journal-title":"Mol Biochem Parasitol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"4809","DOI":"10.1128\/AAC.00713-16","article-title":"Acquired tolerance to ivermectin and moxidectin after drug selection pressure in the nematode Caenorhabditis elegans","volume":"60 8","author":"Menez C","year":"2016","unstructured":"Menez C, Alberich M, Kansoh D, Blanchard A, Lespine A. Acquired tolerance to ivermectin and moxidectin after drug selection pressure in the nematode Caenorhabditis elegans. Antimicrob Agents Chemother. 2016;60 8:4809\u201319; doi: 10.1128\/AAC.00713-16. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27246778.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref69","doi-asserted-by":"publisher","first-page":"e0011868","DOI":"10.1371\/journal.pntd.0011868","article-title":"Cytotaxonomic characterization and estimation of migration patterns of onchocerciasis vectors (Simulium damnosum sensu lato) in northwestern Ethiopia based on RADSeq data","volume":"18","author":"Hedtke SM","year":"2024","unstructured":"Hedtke SM, Post RJ, Feleke SM, Gebretsadik FS, Boakye DA, Krueger A, et al. Cytotaxonomic characterization and estimation of migration patterns of onchocerciasis vectors (Simulium damnosum sensu lato) in northwestern Ethiopia based on RADSeq data. PLoS Negl Trop Dis. 2024;18 1:e0011868; doi: https:\/\/doi.org\/10.1371\/journal.pntd.0011868.","journal-title":"PLoS Negl Trop Dis."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13071-019-3290-5","article-title":"Entomological assessment of the transmission following recrudescence of onchocerciasis in the Como\u00e9 Valley, Burkina Faso","volume":"12 1","author":"Koala L","year":"2019","unstructured":"Koala L, Nikiema AS, Pare AB, Drabo F, Toe LD, Belem AMG, et al. Entomological assessment of the transmission following recrudescence of onchocerciasis in the Como\u00e9 Valley, Burkina Faso. Parasit Vectors. 2019;12 1:34; doi: 10.1186\/s13071-019-3290-5. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30646934.","journal-title":"Parasit Vectors"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.actatropica.2018.05.013","article-title":"Onchocerciasis prevalence, human migration and risks for onchocerciasis elimination in the Upper Mouhoun, Nakambe and Nazinon river basins in Burkina Faso","volume":"185","author":"Niki\u00e8ma AS","year":"2018","unstructured":"Niki\u00e8ma AS, Koala L, Post RJ, Par\u00e9 AB, Kafando CM, Drabo F, et al. Onchocerciasis prevalence, human migration and risks for onchocerciasis elimination in the Upper Mouhoun, Nakambe and Nazinon river basins in Burkina Faso. Acta Trop. 2018;185:176\u201382; doi: 10.1016\/j.actatropica.2018.05.013. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29782820.","journal-title":"Acta Trop"},{"issue":"1","key":"ref72","doi-asserted-by":"publisher","first-page":"e17357","DOI":"10.1111\/mec.17357","article-title":"Synthesizing environmental, epidemiological, and genetic data to understand the persistence of onchocerciasis transmission in the ecological transition region of Ghana","volume":"33","author":"Shrestha H","year":"2024","unstructured":"Shrestha H, McCulloch K, Chisholm RH, Armoo S, Vierigh F, Sirwani N, et al. Synthesizing environmental, epidemiological, and genetic data to understand the persistence of onchocerciasis transmission in the ecological transition region of Ghana. Molec Ecol. 2024;33 1:e17357; doi: 10.1111\/mec.17357.","journal-title":"Molec Ecol."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/tropicalmed8090445","article-title":"Procedure for handling and storage of skin snips for downstream genetic work on Onchocerca volvulus microfilariae","volume":"8 9","author":"Hedtke SM","year":"2023","unstructured":"Hedtke SM, Kode A, Ukety TO, Mande JL, Abhafule GM, Raciu AA, et al. Procedure for handling and storage of skin snips for downstream genetic work on Onchocerca volvulus microfilariae. Trop Med Infect Dis. 2023;8 9:445; doi: 10.3390\/tropicalmed8090445. https:\/\/www.mdpi.com\/2414-6366\/8\/9\/445.","journal-title":"Trop Med Infect Dis"},{"key":"ref74","first-page":"235","article-title":"Studies of reproductive competence in male Dirofilaria immitis treated with milbemycin oxime","volume":"46 4","author":"Lok JB","year":"1995","unstructured":"Lok JB, Knight DH, Selavka CM, Eynard J, Zhang Y, Bergman RN. Studies of reproductive competence in male Dirofilaria immitis treated with milbemycin oxime. Trop Med Parasitol. 1995;46 4:235\u201340. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8826103.","journal-title":"Trop Med Parasitol."},{"key":"ref75","first-page":"451","article-title":"Elimination of human onchocerciasis: progress report, 2024\u20132025 = \u00c9limination de l\u2019onchocercose humaine: rapport de situation, 2024\u20132025","volume":"100 41","author":"World Health Organization\u2009=\u2009Organisation mondiale de la Sant\u00e9","year":"2025","unstructured":"World Health Organization\u2009=\u2009Organisation mondiale de la Sant\u00e9. Elimination of human onchocerciasis: progress report, 2024\u20132025 = \u00c9limination de l\u2019onchocercose humaine: rapport de situation, 2024\u20132025. Weekly Epidemiological Record. 2025;100 41:451\u201360. https:\/\/iris.who.int\/handle\/10665\/383100.","journal-title":"Weekly Epidemiological Record"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10311498\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10311498\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T01:44:01Z","timestamp":1784511841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10311498\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":75,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10311498\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,7,20]]},"subtype":"preprint"}}